Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

It has been reported that antroquinonol extracted from Golden- exerts protective effects on liver function both . However, the protective effects of Golden- on liver function have not been fully investigated in human clinical studies. Therefore, the present study aimed to evaluate the beneficial effects of Golden- on hepatic function after alcohol consumption in human subjects. A total of 80 participants with increased γ-glutamyl transferase levels (60-180 U/L) were enrolled in the current study and were randomly divided into two groups. Participants in the first group were orally administrated with 300 mg/day Golden- (tablets), while those in the second group received placebo tablets for 12 weeks. Biochemical routine blood tests were performed at 6 and 12 weeks following the first administration. At 12 weeks post the first Golden- administration, the serum levels of aspartate aminotransferase (AST; < 0.0001), alanine aminotransferase (ALT; = 0.0002) and triglyceride ( = 0.0158) were notably declined in the Golden- treatment group compared with the placebo group. No clinically significant differences were observed between the Golden- treatment and placebo groups in terms of general safety parameters. A statistically significant difference was obtained in the serum levels of AST, ALT and triglycerides between the Golden- and placebo groups. However, no clinical significance was observed in any of the safety parameters examined. Overall, these findings indicated that treatment with Golden- exerted protective effects on liver function.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253287PMC
http://dx.doi.org/10.3389/fphar.2022.757494DOI Listing

Publication Analysis

Top Keywords

protective effects
12
liver function
12
golden-
10
effects liver
8
effects golden-
8
serum levels
8
golden- treatment
8
placebo groups
8
safety parameters
8
liver
5

Similar Publications

Aims: Chronic ocular diseases such as age-related macular degeneration (AMD) are leading causes of vision loss in older adults. While sodium-glucose co-transporter 2 inhibitors (SGLT2i) are widely prescribed in the management of type 2 diabetes mellitus (T2DM), their effects on ocular disease risk remain largely unknown.

Materials And Methods: This retrospective cohort study evaluated the association between SGLT2i use and the risk of AMD and other age-related ocular conditions in adults aged ≥60 with T2DM, using a target trial emulation framework based on the TriNetX global health research network (2013-2025).

View Article and Find Full Text PDF

Relationships of Circulating Plasma Metabolites With the QT Interval in a Large Population Cohort.

Circ Genom Precis Med

September 2025

Clinical Pharmacology and Precision Medicine, William Harvey Research Institute, London, United Kingdom (W.J.Y., M.M.S., J.R., S.v.D., H.R.W., A.T., P.B.M.).

Background: There is a higher prevalence of heart rate corrected QT (QTc) prolongation in patients with diabetes and metabolic syndrome. QT interval genome-wide association studies have identified candidate genes for cardiac energy metabolism, and experimental studies suggest that polyunsaturated fatty acids have direct effects on ion channel function. Despite this, there has been limited study of metabolite concentration relationships with QT intervals.

View Article and Find Full Text PDF

There is a concern on the safety of cosmetic ingredients and their endocrine-disrupting (ED) potential. Frequent use as well as the use of a diverse range of cosmetics pose a concern for a potential health risk via aggregate exposure to endocrine disrupting chemicals (EDCs). In this study, a list of ingredients available in cosmetic products that were recently introduced to the Dutch market was retrieved from the commercially accessible Mintel database and screened for the presence of EDCs.

View Article and Find Full Text PDF

Degradation during production and delivery is a significant bottleneck in developing biomolecular therapies. Protein cages, formed by engineered variants of lumazine synthase, present an effective strategy for the microbial production and isolation of labile biomolecular therapies. Genetic fusion of the target polypeptide to a cage component protomer ensures its efficient encapsulation within the cage during production in host bacterial cells, thereby protecting it from degradation.

View Article and Find Full Text PDF

Background: Superficial injection of hyaluronic acid (HA)-based gels is a widely used method to restore skin quality and achieve a more youthful appearance. While the clinical benefits of such procedures are well established, their biological mechanisms of action remain poorly understood.

Objective: This study aimed to evaluate the effectiveness of two cross-linked HA gels (IPN-12.

View Article and Find Full Text PDF